Purinergic receptors and gastrointestinal secretomotor function
Open Access
- 5 July 2008
- journal article
- review article
- Published by Springer Nature in Purinergic Signalling
- Vol. 4 (3) , 213-236
- https://doi.org/10.1007/s11302-008-9104-4
Abstract
Secretomotor reflexes in the gastrointestinal (GI) tract are important in the lubrication and movement of digested products, absorption of nutrients, or the diarrhea that occurs in diseases to flush out unwanted microbes. Mechanical or chemical stimulation of mucosal sensory enterochromaffin (EC) cells triggers release of serotonin (5-HT) (among other mediators) and initiates local reflexes by activating intrinsic primary afferent neurons of the submucous plexus. Signals are conveyed to interneurons or secretomotor neurons to stimulate chloride and fluid secretion. Inputs from myenteric neurons modulate secretory rates and reflexes, and special neural circuits exist to coordinate secretion with motility. Cellular components of secretomotor reflexes variably express purinergic receptors for adenosine (A1, A2a, A2b, or A3 receptors) or the nucleotides adenosine 5′-triphosphate (ATP), adenosine diphosphate (ADP), uridine 5′-triphosphate (UTP), or uridine diphosphate (UDP) (P2X1-7, P2Y2, P2Y4, P2Y6, P2Y12 receptors). This review focuses on the emerging concepts in our understanding of purinergic regulation at these receptors, and in particular of mechanosensory reflexes. Purinergic inhibitory (A1, A3, P2Y12) or excitatory (A2, P2Y1) receptors modulate mechanosensitive 5-HT release. Excitatory (P2Y1, other P2Y, P2X) or inhibitory (A1, A3) receptors are involved in mechanically evoked secretory reflexes or “neurogenic diarrhea.” Distinct neural (pre- or postsynaptic) and non-neural distribution profiles of P2X2, P2X3, P2X5, P2Y1, P2Y2, P2Y4, P2Y6, or P2Y12 receptors, and for some their effects on neurotransmission, suggests their role in GI secretomotor function. Luminal A2b, P2Y2, P2Y4, and P2Y6 receptors are involved in fluid and Cl-, HCO3 -, K+, or mucin secretion. Abnormal receptor expression in GI diseases may be of clinical relevance. Adenosine A2a or A3 receptors are emerging as therapeutic targets in inflammatory bowel diseases (IBD) and gastroprotection; they can also prevent purinergic receptor abnormalities and diarrhea. Purines are emerging as fundamental regulators of enteric secretomotor reflexes in health and disease.Keywords
This publication has 123 references indexed in Scilit:
- Sympathetic vasoconstrictor regulation of mouse colonic submucosal arterioles is altered in experimental colitisThe Journal of Physiology, 2007
- Real‐time measurement of serotonin release and motility in guinea pig ileumThe Journal of Physiology, 2006
- International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyPharmacological Reviews, 2006
- Effect of Novel A2AAdenosine Receptor Agonist ATL 313 onClostridium difficileToxin A-Induced Murine Ileal EnteritisInfection and Immunity, 2006
- The P2Y1 purinergic receptor expressed by enteric neurones in guinea‐pig intestineNeurogastroenterology & Motility, 2006
- Effect of Omeprazole on Gastric Adenosine A1 and A2A Receptor Gene Expression and FunctionThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Role of Adenosine A1 Receptor in the Regulation of Gastrin ReleaseThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Role of Adenosine A2A Receptor in the Regulation of Gastric Somatostatin ReleaseThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Adenosine 5‘-O-(1-Boranotriphosphate) Derivatives as Novel P2Y1 Receptor AgonistsJournal of Medicinal Chemistry, 2002
- Neural components of distension‐evoked secretory responses in the guinea‐pig distal colonThe Journal of Physiology, 2001